Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008 Feb-Mar;25(2-3):63-6.
doi: 10.1007/s10815-008-9198-1. Epub 2008 Feb 7.

GnRH agonist for triggering final oocyte maturation in patients at risk of ovarian hyperstimulation syndrome: still a controversy?

S Kol  1 , I Solt
Affiliations
Review

GnRH agonist for triggering final oocyte maturation in patients at risk of ovarian hyperstimulation syndrome: still a controversy?

S Kol et al. J Assist Reprod Genet. 2008 Feb-Mar.

Abstract

Purpose: An update on the subject of ovarian hyperstimulation syndrome (OHSS) prevention with GnRH agonist ovulation trigger.

Methods: Review of pertinent English language studies published during the past 4 years.

Results: Randomized prospective studies support the notion that agonist trigger completely eliminates OHSS. Conflicting results regarding on going pregnancy rate probably reflect different approaches to luteal phase support. Embryos obtained and frozen after agonist trigger yield good clinical outcome in subsequent thaw cycles.

Conclusions: The notion that agonist trigger can eliminate OHSS is strongly supported by randomized controlled trials. Further research is needed to assess optimal luteal support post agonist trigger.

PubMed Disclaimer

References

    1. Hugues J. Ovarian stimulation for assisted reproductive technologies, In: Current practices and controversies in assisted reproduction. Geneva, Switzerland: WHO; 2001, p. 102–126.
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1016/j.fertnstert.2005.07.1292', 'is_inner': False, 'url': 'https://doi.org/10.1016/j.fertnstert.2005.07.1292'}, {'type': 'PubMed', 'value': '16412740', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/16412740/'}]}
    2. Papanikolaou EG, Pozzobon C, Kolibianakis EM, Camus M, Tournaye H, Fatemi HM, et al. Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles. Fertil Steril. 2006;85:112–20. - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1016/j.fertnstert.2003.05.032', 'is_inner': False, 'url': 'https://doi.org/10.1016/j.fertnstert.2003.05.032'}, {'type': 'PubMed', 'value': '14711532', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/14711532/'}]}
    2. Kol S. Luteolysis induced by a gonadotropin-releasing hormone agonist is the key to prevention of ovarian hyperstimulation syndrome. Fertil Steril. 2004;81:1–5. - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1093/humrep/dei475', 'is_inner': False, 'url': 'https://doi.org/10.1093/humrep/dei475'}, {'type': 'PubMed', 'value': '16439507', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/16439507/'}]}
    2. Babayof R, Margalioth EJ, Huleihel M, Amash A, Zylber-Haran E, Gal M, et al. Serum inhibin A, VEGF and TNFalpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial. Hum Reprod. 2006;21:1260–5. - PubMed
    1. Engmann L, DiLuigi A, Schmidt D, Nulsen J, Maier D, Benadiva C. The use of gonadotropin-releasing hormone 9GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization syndrome: a prospective randomized controlled study. Fertil Steril. 2008;89:84–91. - PubMed

Substances

LinkOut - more resources